Article
Establishment and characterization of a novel breast implant-associated anaplastic large cell lymphoma cell line and PDX model (BIA-XR1) with a unique KRAS mutation.
Current research in translational medicine - 1 Jan 2023
Xagoraris Ioanna, Stathopoulou Konstantina, Aulerio Roberta D', He Minghui, Ketscher Anett, Jatta Kenbugul, de Flon Felix Haglund, Barbany Gisela, Rosenquist Richard, Westerberg Lisa S, Rassidakis George Z
Abstract excerpt
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is an uncommon T-cell lymphoma type with distinct clinical, molecular and genetic features. Establishment of BIA-ALCL cell lines and patient-derived xenograft (PDX) models are essential experimental tools to investigate the molecular pathogenesis of the disease. We characterized a novel BIA-ALCL cell line and PDX model, named BIA-XR1, derived...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
